Home > Insider Trading > Exact Sciences Corp

Exact Sciences Corp (EXAS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Is Exact Sciences Corporation (NASDAQ:EXAS) the Gene Therapy Stock with the Greatest Potential?

We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Exact Sciences Corporation (NASDAQ:EXAS) is the gene therapy stock with the greatest potential...

Keep Reading →

June 3rd, 2024 - Hedge Funds News Stock Analysis

9 Best Gene Therapy Stocks to Buy Now

In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and understand the reasons behind...

Keep Reading →

June 3rd, 2024 - Hedge Funds News Stock Analysis

Hedge Funds are Bullish on This Cancer Stock

The healthcare industry is considered to be a fairly defensive sector due to its need.

Keep Reading →

May 27th, 2024 - Hedge Funds News

7 Best Mid-Cap Healthcare Stocks To Buy Now

The healthcare industry is considered to be a fairly defensive sector due to its need.

Keep Reading →

May 27th, 2024 - Hedge Funds News

Exact Sciences Corporation (NASDAQ:EXAS) Q1 2024 Earnings Call Transcript

Operator: Thank you for standing by. My name is Danica, and I will be your conference operator today.

Keep Reading →

May 9th, 2024 - News Transcripts

Here's Why Baron Health Care Fund Reduced Exact Sciences Corporation (EXAS)

Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.

Keep Reading →

April 24th, 2024 - Hedge Fund Investor Letters News

Here’s Why Exact Sciences Corporation (EXAS) Declined in Q1

Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.

Keep Reading →

April 12th, 2024 - Hedge Fund Investor Letters News

Exact Sciences Corporation (NASDAQ:EXAS) Q4 2023 Earnings Call Transcript

Exact Sciences Corporation beats earnings expectations. Reported EPS is $-0.27, expectations were $-0.53.

Keep Reading →

February 22nd, 2024 - News Transcripts

Top 5 CRISPR Stocks To Invest In

Exact Sciences Corporation (NASDAQ:EXAS) specializes in cancer screening and diagnostic test products, operating both in the United States and internationally.

Keep Reading →

February 10th, 2024 - News